L Debusscher
- Hematology top 2%
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 8
- Hematopoietic Stem Cell Transplantation 5
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
- Oncology top 10%
- Neutropenia and Cancer Infections 7
- Cancer Treatment and Pharmacology 4
- Epidemiology top 10%
-
- Acute Lymphoblastic Leukemia research 8
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Jean KlášterskýR. CappelStefan SuciuG. SolbuM. PeetermansR ZittounC CauchiePierre Stryckmans
- Cited by
- HematologyGeneticsOncology
- Partner nations
- BelgiumItalyNetherlands
In The Last Decade
L Debusscher
44 papers receiving 928 citations
Peers
Comparison fields: 5 of 89
- Hematology 450
- Genetics 192
- Oncology 286
- Epidemiology 271
- Critical Care and Intensive Care Medicine 40
Countries citing papers authored by L Debusscher
This map shows the geographic impact of L Debusscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Debusscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Debusscher more than expected).
Fields of papers citing papers by L Debusscher
This network shows the impact of papers produced by L Debusscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Debusscher. The network helps show where L Debusscher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L Debusscher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I-II study of a Farnesyl Transferase Inhibitor (FTI), SCH66336, in patients with myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (sAML). | 2002 | 7 |
| 2 | 1994 | 1 | |
| 3 | 1993 | 23 | |
| 4 | 1993 | 3 | |
| 5 | 1992 | 139 | |
| 6 | The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation. | 1991 | 1 |
| 7 | 1991 | 32 | |
| 8 | 1990 | 10 | |
| 9 | 1990 | 2 | |
| 10 | 1989 | 302 | |
| 11 | 1988 | 8 | |
| 12 | Eosinophilic fasciitis and severe aplastic anemia: favorable response to either antithymocyte globulin or cyclosporine A in blood and skin disorders. | 1988 | 8 |
| 13 | Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia. | 1987 | 14 |
| 14 | 1977 | 23 | |
| 15 | 1977 | 2 | |
| 16 | Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia. | 1976 | 24 |
| 17 | [Diffuse pneumopathy during chemotherapy with busulfan and bleomycin]. | 1973 | 1 |
| 18 | 1973 | 40 | |
| 19 | 1972 | 1 | |
| 20 | Effect of adjustment of the pH upon sensitivity of urinary gram-negative bacilli to nine antibiotics. | 1971 | 2 |
About L Debusscher
L Debusscher is a scholar working on Hematology, Applied Microbiology and Biotechnology and Genetics, having authored 46 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Neutropenia and Cancer Infections (7 papers), Hematopoietic Stem Cell Transplantation (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Hematology (450 citations), Genetics (192 citations) and Oncology (286 citations). L Debusscher has collaborated with scholars based in Belgium, Italy and Netherlands. Frequent co-authors include Jean Klášterský, R. Cappel, Stefan Suciu, G. Solbu, M. Peetermans, R Zittoun, C Cauchie, Pierre Stryckmans, J. Abels and H. Kerkhofs. Their work appears in journals such as Blood, Leukemia Research, Clinical Infectious Diseases, Radiotherapy and Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.